HIV, Gilead and patent infringement
The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...
But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...
Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...
Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...
Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...
Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.
CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...
Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...
The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...
Abia State Agency for the Control of AIDS, ABSACA, has disclosed that 46,788 persons are currently undergoing treatment for ...